---
# jekyll header
---
{% include header.html %}

<!-- ============BreadCrumb=============== -->

{% include container-start.html %}

<!-- ============CONTENT CONTENT=============== -->

<h2>
  CodeSystems defined as part of this Implementation Guide:
</h2>

<h3>Code Systems</h3>
<table class="codes">
  <thead>
    <tr>
      <td>
        <b>Name</b>
      </td>
      <td>
        <b>Definition</b>
      </td>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="CodeSystem-oncology-BreastCancerMCategoryCS.html">BreastCancerMCategoryCS</a></td>
      <td>Codes that designate concepts describing Metastases category according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-BreastCancerNCategoryCS.html">BreastCancerNCategoryCS</a></td>
      <td>Codes that designate concepts describing Node category according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-BreastCancerStageCS.html">BreastCancerStageCS</a></td>
      <td>Codes that designate concepts describing breast cancer stage group, according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-BreastCancerTCategoryCS.html">BreastCancerTCategoryCS</a></td>
      <td>Codes that designate concepts describing stages for Tumor category according to AJCC breast cancer staging recommendations.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-BreastCancerTypeCS.html">BreastCancerTypeCS</a></td>
      <td>Histologic types of breast cancer. Codes are drawn from ICD-O-3.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-BreastSiteCS.html">BreastSiteCS</a></td>
      <td>Topography of the breast. Codes are drawn from ICD-O-3.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-BreastSpecimenCollectionMethodCS.html">BreastSpecimenCollectionMethodCS</a></td>
      <td>The surgical method used to obtain the tissue sample.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-BreastSpecimenTypeCS.html">BreastSpecimenTypeCS</a></td>
      <td>The type of specimen obtained from the breast.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-condition-ConditionCategoryCS.html">ConditionCategoryCS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-DegreeOfLymphaticInvolvementCS.html">DegreeOfLymphaticInvolvementCS</a></td>
      <td>Value set containing the degree of lymphatic involvement.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-finding-DiagnosticServiceCS.html">DiagnosticServiceCS</a></td>
      <td>The type of laboratory service used in producing a laboratory result</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-entity-DirectionalityCS.html">DirectionalityCS</a></td>
      <td>Anatomical location or specimen further detailing directionality. Codes are from NCI</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-finding-ExceptionValueCS.html">ExceptionValueCS</a></td>
      <td>Reasons that a value associated with a test or other finding is missing. Extended set based on http://hl7.org/fhir/ValueSet/observation-valueabsentreason</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-HER2ISHMethodCS.html">HER2ISHMethodCS</a></td>
      <td>Value set containing In Situ Hybridization methods of determining HER2 status</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-HER2MethodCS.html">HER2MethodCS</a></td>
      <td>Value set containing methods of determining HER2 status</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-HER2StatusCS.html">HER2StatusCS</a></td>
      <td>HER2 status overall result</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-entity-LateralityCS.html">LateralityCS</a></td>
      <td>Anatomical location or specimen further detailing the side(s) of interest. Codes are from NCI</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-LeftRightLateralityCS.html">LeftRightLateralityCS</a></td>
      <td>Simplified set of laterality codes indicating detailing the side(s) of interest. Codes are from NCI</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-MammaprintRiskScoreInterpretationCS.html">MammaprintRiskScoreInterpretationCS</a></td>
      <td>Intepretation of Mammaprint Recurrence Score</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-MorphologyBehaviorCS.html">MorphologyBehaviorCS</a></td>
      <td>The morphologic behavior of the cancer. These are the suffix to the ICD-O-3 histologic type codes</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-NuclearGradeCS.html">NuclearGradeCS</a></td>
      <td>The nuclear grade describes how closely the nuclei of cancer cells look like the nuclei of normal breast cells. In general, the higher the nuclear grade, the more abnormal the nuclei are and the more aggressive the tumor cells tend to be. The nuclear grade is a part of overall tumor grade.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-OncotypeDxDCISRiskScoreInterpretationCS.html">OncotypeDxDCISRiskScoreInterpretationCS</a></td>
      <td>Intepretation of OncotypeDX DCIS (Ductal Carcinoma In Situ) Recurrence Score</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-OncotypeDxInvasiveRiskScoreInterpretationCS.html">OncotypeDxInvasiveRiskScoreInterpretationCS</a></td>
      <td>Intepretation of OncotypeDX Recurrence Score for invasive cancers.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-entity-PortionTotalityCS.html">PortionTotalityCS</a></td>
      <td>Further detail of the anatomical location or specimen detailing whether it includes the entire entity or only a part or portion.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-PositiveNegativeEquivocalCS.html">PositiveNegativeEquivocalCS</a></td>
      <td>Interpretation of a test result as positive, negative or equivocal.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-RecurrenceRiskScoreInterpretationCS.html">RecurrenceRiskScoreInterpretationCS</a></td>
      <td>Interpretations of risk as high, intermediate, or low. Answer set taken from LOINC LL3198-0</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-StageTimingPrefixCS.html">StageTimingPrefixCS</a></td>
      <td>When staging was done, relative to treatment events.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-StagingMethodCS.html">StagingMethodCS</a></td>
      <td>The methodology or standard used to do the staging.</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-oncology-StainingIntensityCS.html">StainingIntensityCS</a></td>
      <td>Part of the Allred scoring, based on the intensity of that staining, on a scale of 0 (Negative) to 3 (Strong).</td>
    </tr>
    <tr>
      <td><a href="CodeSystem-shr-core-YesNoCS.html">YesNoCS</a></td>
      <td></td>
    </tr>
    <tr>
      <td><a href="CodeSystem-shr-core-YesNoUnknownCS.html">YesNoUnknownCS</a></td>
      <td></td>
    </tr>
    
  </tbody>
</table>

<!-- ==============END CONTENT END CONTENT=================== -->

{% include container-end.html %}
{% include footer.html %}